Ricci et al.
9-Ch lor o-16r-m eth yl-11â,17r,20,21-tetr a h yd r oxy-18,20-
cyclop r egn a -1,4-d ien -3-on e 17,21-d ip r op ion a te (14a ). 1H
NMR(CDCl3): δ 1.15 (t, J ) 7, 3H, Me), 1.2 (t, J ) 7, 3H, CH3),
1.25 (d, J ) 7, 3H, CH3), 1.6 (s, 3H, Me), 2.3-2.4 (m, 4H, CH2),
1.2-2.8 (m, 15H), 4.55 (m, 1H, H-11), 4.5 and 4.7 (m, 2H, AB
system, J ) 18, CH2-21), 6.05 (bt, J ) 1.5, 1H, H-4), 6.4 (dd,
J ) 10, 1.5, 1H, H-2), 7.2 (d, J ) 10, 1H, H-1). 13C NMR
(CDCl3): δ 8.9 (CH3), 9.1 (CH3), 18.9 (CH3), 24.2 (CH2), 24.2
(CH3), 26.6 (CH2), 27.5 (CH2), 30.4 (CH2), 31.1 (CH2), 34.3 (CH),
37.7 (CH2), 39.2 (CH2), 40.3 (CH), 46.5, 48.4 (CH), 49.6 (C-
10), 67.9 (CH2-21), 75.3 (CH-11), 77.7 (C-9), 82.2 (C-20), 94.4
(C-17), 124.8 (CH-4), 129.3 (CH-2), 151.7 (CH-1), 165.5 (C-5),
174.7 (COOR), 174.9 (COOR), 186.3 (C-3).
9-Ch lor o-16r-m eth yl-11â,17r,20,21-tetr a h yd r oxy-18,20-
cyclop r egn a -1,4-d ien -3-on e 17,21-d ip r op ion a te (14b). 1H
NMR (CDCl3): δ 1.18 (t, J ) 7, 3H, Me), 1.22 (s, 3H, CH3),
1.25 (d, J ) 7, 3H, Me), 1.65 (s, 3H, Me), 2.3-2.4 (m, 4H, CH2),
1.2-2.8 (m, 15H), 4.4 (m, 1H, H-11), 4.3 and 5.1 (m, 2H, AB
system, J ) 18, CH2-21), 6.05 (bt, J ) 1.5, 1H, H-4), 6.42 (dd,
J ) 10, 1.5, 1H, H-2), 7.22 (d, J ) 10, 1H, H-1). 13C NMR
(CDCl3): δ 8.5 (CH3), 8,7 (CH3), 18.6 (CH3), 24.2 (CH3), 27.2
(CH2), 27.3 (CH2), 27.4 (CH2), 28.2 (CH2), 31.2 (CH2), 34.3 (CH),
37.4 (CH2), 39.2 (CH2), 40.3 (CH), 45.2, 48.0 (CH), 49.8, 63.6
(CH2-21), 75.6 (CH-11), 77.9 (C-9), 86.3 (C-20), 87.0 (C-17),
124.8 (CH-4), 129.3 (CH-2), 151.9 (CH-1), 165.6 (C-5), 173.3
(COOR), 174.7 (COOR), 186.3 (C-3).
1H NMR (CDCl3): δ 0.93 (t, 3H, J ) 7 Hz, CH3), 0.98 (d, 3H,
J ) 7 Hz, CH3), 1.45 (s, 3H, CH3, Me-19), 1.4 (m, 2H), 1.65
(m, 2H, J ) 7 Hz), 2.46 (t, 2H, J ) 7 Hz), 4.3 (m, 1H, H-11),
4.62 (AB system, 2H, H-21), 5.0 and 5.05 (bs, 2H, CH2-18),
5.3 (dddd, J ) 50, 13, 8, 2 Hz, 1H, H-6), 6.4 (d, J ) 10 Hz, 1H,
H-2), 6.45 (bs, 1H, H-4), 7.14 (d, J ) 10 Hz, 1H, H-1), 1.3-2.8
(m, 11H + OH). 13C NMR (CDCl3): δ 13.4 (CH3), 20.9 (CH3),
21.9 (CH2), 23.05 (d, J ) 5 Hz, CH3 Me-19), 26.7 (CH2), 27.0
(CH), 33.3 (CH2), 33.4 (d, J ) 23 Hz, CH2-7), 35.1 (CH2), 39.4
(dd, J ) 18, 8 Hz, CH-8), 40.5 (CH2), 40.8 (CH), 44.6 (CH2),
47.3 (d, J ) 10 Hz, C-10), 68.0 (CH2), 68.9 (d, J ) 35 Hz, CH-
11), 86.3 (d, J ) 175 Hz, CH-6), 98.0 (d, J ) 175 Hz, C-9),
112.3 (CH2-18), 120.9 (d, J ) 10 Hz, CH-4), 130.0 (CH-2), 149.7
(C-13), 149.7 (CH-1), 160.2 (C-5), 172.9 (COOR), 184.9 (C-3),
203.1 (CO).
6r,9-Diflu or o-16r-m et h yl-11â,20,21-t r ih yd r oxy-18,20-
cyclopr egn a-1,4-dien -3-on e 21-valer ate (17). Colorless crys-
tals; mp 105 °C; [R]D +42°. IR: 3250, 2690, 1660, 1620, 900
cm-1. Anal. Cald for C27H36F2O5: C, 67.76; H, 7.58. Found: C,
676.72; H, 7.63. 1H NMR (CDCl3): δ 0.92 (t, J ) 7 Hz, 3H),
0.94 (d, J ) 7 Hz, 3H), 1.37 (ses, 2H, butyl methylene), 1.48
(s, 3H, Me-19), 1.65 (qui, 2H, butyl methylene), 1.9 (d, J ) 4
Hz, 1H, H-17), 2.1 (exch, 2H, OH), 2.0 (m, 1H, H-16), 2.0 and
2.4 (m, 2H, H-12), 2.35 (t, J ) 7 Hz, 2H, buthyl methylene),
1.5-2.2 (m, 8H), 4.0 (AB system, 2H), 4.4 (m, 1H), 5.4 (dddd,
J ) 50, 13, 8, 2 Hz, 1H), 6.35 (dd, J ) 10, 2 Hz, 1H), 6.43 (bs,
J ) 2 Hz, 1H), 7.1 (d, J ) 10 Hz, 1H). The C-20 configuration
was attributed on the basis of NOESY experiment: a cross-
peak between H-21 (4.0 ppm) and the hydrogen at 2.02 ppm
(attributed to H-18) was apparent, whereas no correlations
with H-17 (1.9 ppm) and with the methyl group in position 16
were found. A cross-peak between H-17 and the methyl in 16
position was apparent, confirming their spatial closeness.
Thus, in the cyclobutane ring the hydroxy group was cis to
H-17, whereas the chain was at the opposite side.
13C NMR (CDCl3): δ 13.5 (CH3), 22.0 (CH2), 22.5 (CH3), 23.0
(d, J C-F ) 5 Hz, CH3), 26.9 (CH2), 32.3 (dd, J C-F ) 18, 8 Hz,
CH-8), 32.8 (CH2), 33.8 (CH), 33.9 (d, J C-F ) 23 Hz, CH2-7),
33.9 (CH2), 34.2 (CH2), 35.8 (CH2), 41.2 (CH2), 43.7, 43.9 (CH),
48.1 (d, J C-F ) 27 Hz, C-10), 60.1 (CH-17), 66.9 (CH2), 72.5
(C-20), 72.5 (d, J C-F ) 36 Hz, CH-11), 86.4 (d, J C-F ) 175 Hz,
CH-6), 99.1 (d, J C-F ) 175 Hz, C-9), 120.9 (d, J C-F ) 13 Hz,
CH-4), 129.9 (CH-2), 150.7 (CH-1), 161.3 (d, J C-F ) 10 Hz, C-5),
174.0 (COOR), 185.5 (C-3).
Qu a n tu m Yield s Mea su r em en ts. A total of 3 mL of an
acetonitrile solution (2.5 × 10-3 M for all of the steroids, but
2 × 10-4 M for beclomethasone base) of the pregnane deriva-
tives were irradiated in spectrophotometric sealed cuvettes.
The light source was a low-pressure mercury arc lamp for 254
nm and a focalized high-pressure mercury arc lamp with the
appropriate interference filter for 313 and 366 nm. The fraction
of light absorbed was measured by means of a photon counter
placed behind the cuvette. The steroids conversion was deter-
mined by HPLC analyses. The light flux was measured by
ferrioxalate actinometry.
P h ot olysis of Diflu cor t olon e-21-va ler a t e (13) a t 254
n m . A solution of compound 13 (1 g, 2.1 mmol) in acetonitrile
(420 mL) was irradiated for 7 h, and 60% conversion was
reached. Chromatographic separation of the residue (eluting
with a cyclohexane-ethyl acetate, 80/20 mixture) gave 300 mg
(50%) of compound 15.
6r,9-Diflu or o-16r-m eth yl-11â,21-d ih yd r oxy-1,5-cyclo-
p r egn a -3-en -2,20-d ion e 21-va ler a te (15). Colorless crystals;
mp 220 °C (AcOEt); [R]D +8°. IR: 3490, 2954, 1721, 1685, 1172,
968 cm-1. Anal. Calcd for C27H36F2O5 C, 67.76; H, 7.58.
1
Found: C, 67.88; H, 7.31. H NMR (CDCl3): δ 0.9 (s, 3H, Me-
18), 0.93 (d, J ) 7, 3H), 0.98 (t, J ) 7, 3H), 1.3 (s, 3H, Me-19),
1.6 (m, 2H, CH2), 2.45 (t, J ) 7, 2H, CH2-CO), 2.75 (m, 1H,
H-16), 4.33 (m, 1H, H-11), 4.45 and 4.7 (AB system, J ) 17,
2H, H-21), 5.2 (dt, J ) 53, 7.5, 1H, H-6), 6.1 (d, J ) 5.5, 1H,
H-3), 7.67 (d, J ) 5.5, 1H, H-4). 13C NMR (CDCl3): δ 7.89
(CH3), 13.4 (CH3), 15.5 (CH3), 21.6 (CH3), 21.9 (CH2), 26.6
(CH2), 27.6 (d, J ) 23, CH2-7), 29.1 (dd, J ) 18.8, CH-8), 30.9
(CH), 32.6 (CH2), 33.2 (CH2), 36.0 (t, J ) 7, CH-1), 41.6 (CH2),
44.8, 46.8 (CH), 52.3 (d, J ) 27, C-10), 68.8 (d, J ) 35, CH-
11), 69.1 (CH2-21), 86.5 (d, J ) 175, CH-6), 94.8 (d, J ) 175,
C-9), 133.6 (CH-3), 159.8 (d, J ) 10, CH-4), 172.9 (COOR),
202.8 (C-2), 203.6 (C-20).
P h otolysis of Diflu cor tolon e-21-va ler a te a t 310 n m . A
solution of compound 13 (1 g, 2.1 mmol) in acetonitrile (420
mL) was irradiated for 4 h, when 50% conversion was reached.
Column chromatography (eluting with cyclohexane/ethyl ac-
etate 80/20) afforded the following photoproducts: 15, 20 mg
(20%); 16, 125 mg (30%) and a cyclobutanol derivative identi-
fied as 17, 20 mg (5%).
6r,9-Diflu or o-16r-m eth yl-11â,21-d ih yd r oxy-13-m eth yl-
en e-18-n or -13,17-seco-p r egn a -1,4-d ien -3,20-d ion e 21-va l-
er a te (16). Colorless crystals; mp 190 °C (AcOEt); [R]D +10°.
IR: 3300, 2960, 1725, 1660, 1620, 1075, 900 cm-1. Anal. Calcd
for C27H36F2O5: C, 67.76; H, 7.58. Found: C, 67, 8; H, 7.61.
Ack n ow led gm en t. Partial support of this work by
MIUR, Rome, and ISS, Rome, is gratefully aknowledged.
J O034070A
4366 J . Org. Chem., Vol. 68, No. 11, 2003